Phenom, an AI company specializing in HR, announced 42 additions to its rapidly expanding IAMPHENOM 2025 speaker lineup — ...

Germany’s Merck KGaA is in advanced talks to aquire the U.S. biopharmaceutical company that specializes in rare diseases and ...

Stamford-based SpringWorks Therapeutics, a commercial-stage biotech company developing treatments for rare diseases and ...

EQS-Adhoc: Merck KGaA: Merck KGaA confirms discussions with Springworks Therapeutics, Inc. on potential acquisition ...

Merck has not shied away from splashy takeovers in the past. In 2015, the company agreed to buy U.S. lab equipment supplier ...

EMD Electronics, the North American pigments division of Merck KGaA, Darmstadt, Germany, has launched Ronaflux® cosmetic ...

In this manuscript the authors established a novel three-dimensional culture system for stratified epithelia that allows epithelial cells to undergo epithelial-to-mesenchymal transition (EMT) and ...

AQILION AB (publ) announces that the Company has resumed development of the its TAK1 program as the company has regained the control and ownership of the program. After reviewing and analysing the ...

In the wake of AI, unprecedented demand for data and computing power is outstripping capabilities. This will drive the ...

Quantinuum today announced a groundbreaking Generative Quantum AI framework (Gen QAI) – leveraging unique quantum-generated ...

Celebrating its sixth annual tour, the Curiosity Cube from MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, traveled across North America and Europe during ...